13F Data
13F filer · CIK 1571076

Aisling Capital LLC

New York, NY · filing since Q4 2013 · last filing Nov 13, 2019
Reported value
$45.3M
$-15.1M vs prior
Positions
5
New / sold out
1 / 0
Added / reduced
0 / 2
Turnover
0.0%
buys $0 · sells $16.0M
Top-10 weight
100.0%

Biggest buys vs Q2 2019

ChangeSecurityShares changeChange %Est. trade value
NewVIEWRAY INC.+18,964–$0

Biggest sells vs Q2 2019

ChangeSecurityShares changeChange %Est. trade value
ReducedAIMMUNE THERAPEUTICS INC.-750,000-37.7%$-15.7M
ReducedCIDARA THERAPEUTICS INC.-129,534-12.7%$-258.5K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2013: $163.6MQ1 2014: $143.9MQ2 2014: $346.0MQ3 2014: $515.7MQ4 2014: $659.6MQ1 2015: $764.2MQ2 2015: $671.6MQ3 2015: $568.8MQ4 2015: $579.8MQ1 2016: $499.4MQ2 2016: $423.5MQ3 2016: $485.4MQ4 2016: $430.1MQ1 2017: $549.3MQ2 2017: $583.9MQ3 2017: $608.7MQ4 2017: $506.2MQ1 2018: $561.1MQ2 2018: $761.9MQ3 2018: $462.7MQ4 2018: $353.1MQ1 2019: $66.5MQ2 2019: $60.3MQ3 2019: $45.3M
Q4 2013Q3 2019

Holdings · Q3 2019

#SecuritySharesValueWeight
1AIMMUNE THERAPEUTICS INC.COM1,240,000$26.0M57.34%
2ADMA BIOLOGICS INCCOM3,608,171$16.1M35.46%
3CIDARA THERAPEUTICS INC.COM891,614$1.8M3.93%
4TRANSENTERIX INC.COM NEW2,389,352$1.5M3.27%
5VIEWRAY INC.COM18,964$00.00%